Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging (Q37641049)

21 August 2017

1 reference

title

Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging (English)

1 reference

chronic renal insufficiency

21 August 2017

0 references

1 reference

Helen Vlassara

1 reference

21 August 2017

Massimo Torreggiani

1 reference

21 August 2017

James B Post

1 reference

21 August 2017

Feng Zheng

1 reference

21 August 2017

Jaime Uribarri

1 reference

21 August 2017

Gary E Striker

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Kidney International. Supplement

21 August 2017

published in

1 reference

21 August 2017

issue

114

1 reference

21 August 2017

page(s)

S3-11

1 reference

Prevalence of chronic kidney disease in the United States

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Manifestations of oxidant stress in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

High basal metabolic rate is a risk factor for mortality: the Baltimore Longitudinal Study of Aging.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Longitudinal studies on the rate of decline in renal function with age.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Acute kidney injury in the elderly: problems and prospects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Acute kidney injury: epidemiology and assessment.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Incidence of severe acute renal failure in adults: results of a community based study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The impact of aging on kidney repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Acute kidney injury increases risk of ESRD among elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The aging pandemic: demographic changes in the general and end-stage renal disease populations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

RAGE ligation affects T cell activation and controls T cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Advanced glycoxidation end products in commonly consumed foods

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Renal catabolism of advanced glycation end products: the fate of pentosidine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Cardiovascular implications of chronic kidney disease in older adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Obesity, inflammation, and kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Cognitive impairment in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Prevalence, recognition, and implications of mental impairment among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Cognitive impairment in hemodialysis patients is common.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Elevated risk of stroke among patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Heart disease and single-vitamin supplementation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Adherence to Mediterranean diet and health status: meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Effectiveness of the Mediterranean diet in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Aging in rodents fed restricted diets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.401

7 January 2021

Identifiers

DOI

10.1038/KI.2009.401

1 reference

21 August 2017

1 reference